LeMaitre Q1 2024 Financial Results
02 mai 2024 16h05 HE
|
LeMaitre Vascular, Inc.
BURLINGTON, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q1 2024 results, announced a $0.16/share quarterly...
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
02 mai 2024 16h05 HE
|
Cardiff Oncology, Inc.
- In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev naïve patients and support ongoing first-line RAS-mutated...
Kura Oncology Reports First Quarter 2024 Financial Results
02 mai 2024 16h05 HE
|
Kura Oncology, Inc.
– Breakthrough Therapy Designation for ziftomenib in NPM1-mutant AML – – Registration-directed trial of ziftomenib in NPM1-mutant AML on track to complete enrollment by mid-2024 – – Positive...
EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
02 mai 2024 16h03 HE
|
EMCORE Corporation
EMCORE Corporation to Host Fiscal 2024 Second Quarter Conference Call on May 8, 2024
Gevo Reports First Quarter 2024 Financial Results
02 mai 2024 16h01 HE
|
Gevo, Inc.
ENGLEWOOD, Colo., May 02, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the first quarter 2024 and recent...
aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
02 mai 2024 16h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma announces first quarter 2024 results and provides corporate update
Complete Solaria to be Self-Funded in Q2 2024
02 mai 2024 14h30 HE
|
Complete Solaria Inc.
Complete Solaria reported earnings today and announced the Company will be self-funded in Q2 2024.
SuRo Capital Corp. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
02 mai 2024 13h00 HE
|
SuRo Capital Corp.
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) (Nasdaq: SSSS) today announced that it will report its financial results for the quarter ended March 31, 2024 after the...
Virios Therapeutics to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
02 mai 2024 09h15 HE
|
Virios Therapeutics
ATLANTA, May 02, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat...
Motorsport Games to Report First Quarter 2024 Financial Results
02 mai 2024 09h00 HE
|
Motorsport Games Inc.
Motorsport Games to is scheduled to report Q1 2024 financial results on May 7 2024 after market